In recent years, gene
synthesis services have attracted huge attention from researchers on the
account of customer service offerings with cost-efficient quality and pricing.
Custom services aid in reducing errors and unwanted genes, which eventually save
the researcher’s time.
Key service providers operating
in the gene synthesis market provide an exclusive scope of service offerings such
as express gene synthesis (offer gene synthesis service in 3-4 business days),
standard gene synthesis, complex gene services (offer service for project
requirement), and custom gene services. With a range of applications, gene
synthesis services also provide several therapeutics, diagnostics, and R&D
Future Market Insights (FMI), in its recently published study, forecasts that the gene synthesis market will experience a major upturn post-2025, crossing a valuation of US$ 1 Bn in the same year.
For more insights into the Market, request a sample of this report@https://www.futuremarketinsights.com/reports/sample/rep-gb-5924
“Increased requirement for biopharmaceutical and
genomic research company’s focus on the manufacturing of genomic medicine have
directed key market players to provide customized and efficient gene synthesis
service provisions,” says the FMI
Key Takeaways of Gene Synthesis Market Study
- Gene synthesis
services continue to witness higher adoption than gene fragment services and
GMO gene synthesis, accounting for over 45% of the total revenue.
- On account of
low service demand and cost, standard gene synthesis is highly preferred among
- Research &
development activities remain a key application area, as researchers majorly
prefer gene synthesis services over other services for their projects.
- Academic &
research institutes emerge as top end users and are anticipated to contribute
over 50% to the total market value during the forecast period (2019-2029).
- North America
is the biggest revenue generating market, in the view of sophisticated and
well-established service laboratories.
- East Asia is
likely to provide more lucrative prospects for market players, owing to rising
healthcare plans which fund genomic research.
Acquisition Remains Key Strategy for Leading Market
Leading stakeholders in the gene synthesis market are centering on the acquisition of regional market players to heighten their product portfolio and increase their regional existence. For example, in August 2019, Eurofins Scientific elaborated its gene synthesis capacities with the acquisition of Blue Heron Biotech. In addition, in January 2018, Eurofins amplified its footprint in Asia with the acquisition of Tsing Hua in Taiwan.
For information on the research approach used in the report, request methodology@https://www.futuremarketinsights.com/askus/rep-gb-5924
Market Players to Address Molecular Services for Competitive
While the gene synthesis market comprises of various small- and large-scale players, there are restricted companies entirely concentrated on offering molecular services. Continuing the only center on molecular services amends the quality of service, customer loyalty, in addition to an established distribution network that ensures product availability, worldwide. Research & development expenditure on life sciences has been soaring and is likely to expand stably in the forthcoming years. Participants investing in delivering molecular diagnostics services to provide to research prerequisites would be well placed for outsized returns.
Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in London, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and take critical decisions with confidence and clarity amidst breakneck competition
Mr. Abhishek Budholiya
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
T (UK): + 44-(0)-20-7692-8790
Press Office: Press@futuremarketinsights.com